Calendar CalciMedica, Inc. OTC Markets

Equities

CALC

US38942Q2021

Market Closed - OTC Markets 21:30:01 16/07/2024 BST 5-day change 1st Jan Change
4.88 USD +1.46% Intraday chart for CalciMedica, Inc. +9.91% +70.63%

Chart calendar CalciMedica, Inc.

692159b9f2a525dcfcd11e22.V2xm7watEoIK0Qkf68Xp02zMa6zfyVM5xhAbTLr0ad8.AStfl2fMXvJcvUtV3YCnm1-uU-eSlmdppylxPcmSPrwkPA2tMfx253qjWA~a546aefb2a241708673c5e883bfc303b

Upcoming events on CalciMedica, Inc.

07/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)

Past events on CalciMedica, Inc.

15/07/2024 18:15 Jones Healthcare Seaside Summit
15/07/2024 16:00 H.C. Wainwright Kidney Virtual Conference
27/06/2024 13:30 CARPO Phase 2b Trial Results Call
18/05/2024 17:30 Digestive Disease Week Conference - Poster #: Sa1468
13/05/2024 21:05 Q1 2024 Earnings Release
28/03/2024 11:00 Q4 2023 Earnings Release
12/03/2024 21:30 International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference
14/02/2024 15:40 Oppenheimer Healthcare Life Sciences Conference
08/12/2023 American Society of Hematology Meeting
09/11/2023 12:00 Q3 2023 Earnings Release
13/09/2023 18:30 H.C. Wainwright Global Investment Conference
10/08/2023 21:05 Q2 2023 Earnings Release
15/05/2023 13:55 Q1 2023 Earnings Release
10/11/2022 21:58 Q3 2022 Earnings Release
11/08/2022 12:30 Interim 2022 Earnings Release
13/07/2022 18:32 OIS Retina Innovation Summit - Spotlight on Drug Delivery & Durability
02/06/2022 17:00 Annual General Meeting
21/05/2022 22:20 Clinical Trials at the Summit Meeting Conference
10/05/2022 21:05 Q1 2022 Earnings Release
04/05/2022 19:30 Association for Research in Vision and Ophthalmology Meeting

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00


0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00


-38,0
-38,9
2.27%

-23,8

EBIT
Million USD
Released
Forecast
Spread
0,00


0,00


-38,1
-39,6
3.85%

-23,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


0,00


-34,4
-35,9
4.3%

-18,5

Net income
Million USD
Released
Forecast
Spread
-23,5


-14,5


-34,4
-35,9
4.3%

-18,5

EPS
USD
Released
Forecast
Spread
-8,65


-5,08


-7,66
-11,4
33.01%

-1,56

Announcement Date20/01/2304/04/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread









-4,30
-5,10
15.69%
-5,75
-5,10
-12.78%

-5,50


-6,70


-5,90

EBIT
Million USD
Released
Forecast
Spread
-22,3
-4,00
-458.5%
-6,58
-5,95
-10.64%
-4,83
-6,50
25.65%
-4,32
-6,50
33.55%
-5,77
-7,40
22.07%

-6,35


-5,40


-5,60

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-19,3
-4,00
-382.2%
-6,30
-5,90
-6.85%
-4,62
-6,50
28.94%
-4,15
-5,70
27.26%
0,13
-6,60
101.97%

-5,73


-6,53


-6,37

Net income
Million USD
Released
Forecast
Spread
-19,3
-4,00
-382.2%
-6,30
-5,90
-6.85%
-4,62
-6,50
28.94%
-4,15
-5,70
27.26%
0,13
-6,60
101.97%

-5,73


-6,53


-6,37

EPS
USD
Released
Forecast
Spread
-3,41
-0,73
-366.66%
-1,11
-1,05
-6.22%
-0,82
-1,14
28.07%
-0,23
-1,00
77%
0,01
-0,74
101.35%

-0,53


-0,58


-0,42

Announcement Date12/05/2310/08/2309/11/2328/03/2413/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise